Trial intelligence / Profile preview

Plasma Concentration of Oral Ketamine in Chronic Neuropathic Pain

NCT02016664Completed

Start
Apr 2014
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of ketamine in chronic neuropathic pain. Primary endpoint: Plasma level of oral ketamine and norketamine. Started Apr 2014; status: completed.

02

Drugs

ketamine
03

Conditions

chronic neuropathic pain

Beyond the preview

Go deeper on NCT02016664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02016664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call